Cardlytics (CDLX) R&D/CAPEX US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
R&D/CAPEX, % 173.3% 303.3% 408.9% 403.6% 414.4%   228.0%  
Changes by years, y/y, % +67pp +130pp +106pp -5pp +11pp     +13.4%

Cardlytics. R&D/CAPEX, %

Cardlytics. R&D/CAPEX, changes, pp

Cardlytics (CDLX) R&D/CAPEX US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
R&D/CAPEX, % 395.1% 338.4% 274.9% 277.3% 137.4%   228.0%
Changes by years, y/y, % -21pp -131pp -164pp -263pp -258pp    
Changes by quarters, q/q, % -145pp -57pp -64pp +2pp -140pp    

Cardlytics. R&D/CAPEX, %

Cardlytics. R&D/CAPEX, changes, pp

Cardlytics. R&D/CAPEX, changes, pp